OTCMKTS:MDCL Medicine Man Technologies (MDCL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About Medicine Man Technologies Stock (OTCMKTS:MDCL) Get MDCL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume84,948 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Medicine Man Technologies, Inc., formerly known as Medicine Man Technologies and now operating under the Schwazze name, is a cannabis company focused on cultivation, manufacturing, retailing and branded cannabis products. Its business has included dispensaries, cultivation facilities and product manufacturing operations serving adult-use and medical cannabis consumers. The company has operated primarily in Colorado and expanded its presence into New Mexico through acquisitions and retail operations. Its portfolio has included cannabis retail and product brands such as Star Buds, R. Greenleaf, Everest and other regionally focused brands, as well as the Medicine Man and Colorado Harvest Company businesses in Colorado. Medicine Man Technologies was founded to provide cannabis-related products and services and later pursued a broader, multi-state operating strategy. The company adopted the Schwazze corporate identity as it expanded beyond its original Colorado focus. Its operations and leadership have evolved through acquisitions and changes in corporate strategy.AI Generated. May Contain Errors. Read More Receive MDCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicine Man Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDCL Stock News HeadlinesMedicine Man Technologies (SHWZ) Price Target Decreased by 33.33% to 2.04September 30, 2025 | msn.comMedicine Man Technologies Appoints Interim CFO Bob FinleyApril 21, 2025 | tipranks.comA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names distributes income every single Thursday, with payouts reported as high as $1,051 a month. Chief Income Strategist Tim Plaehn breaks down the fund's real Thursday distribution history, how the income is generated, and how to buy it in any brokerage account.October 6 at 1:00 AM | Investors Alley (Ad)Medicine Man Technologies (OTC:SHWZ) Stock Quotes, Forecast and News SummaryNovember 9, 2024 | benzinga.comRevolutionary brain-computer system allows man with MND to ‘speak’ againAugust 16, 2024 | msn.comMedicine Man Technologies Inc.February 14, 2024 | wsj.com13 Action News Big Story: Advancing MedicineNovember 20, 2023 | msn.comLexington native Dr. Drew Weissman who won Nobel Prize in medicine tells reporters he first thought it was a ‘prank’October 2, 2023 | msn.comSee More Headlines MDCL Stock Analysis - Frequently Asked Questions How do I buy shares of Medicine Man Technologies? Shares of MDCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medicine Man Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medicine Man Technologies investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Organigram Global (OGI), TREES (CANN) and Cronos Group (CRON). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:MDCL Previous SymbolNASDAQ:MDCL CIK1622879 Webschwazze.com Phone(303) 371-0387FaxN/AEmployees390Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:MDCL) was last updated on 10/6/2026 by MarketBeat.com Staff. From Our PartnersThe AI Infrastructure Rush Is ON — Watch VDTAVertical Data Inc (OTCQB: VDTA) is building beneath the AI boom, targeting GPU hardware and financing, managed...Trading Wire | SponsoredNvidia’s record quarter could send this new type of AI soaringNvidia just posted 96.2 billion in revenue for a single quarter, more than Coca-Cola generates in an entire ye...Brownstone Research | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredThis smart glasses tech is bringing the screen to your eyesGlobal AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...The Tomorrow Investor | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicine Man Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicine Man Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.